Hypertrophic Cardiomyopathy - Past, Present and Future [PDF]
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a prevalence of 1 in 500 in the general population. Since the first pathological case series at post mortem in 1957, we have come a long way in its understanding, diagnosis ...
Brock +5 more
core +2 more sources
The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. [PDF]
OBJECTIVES: Aortoseptal angulation (AoSA) can predict provocable left ventricular outflow tract obstruction (LVOTO) in patients with symptomatic hypertrophic cardiomyopathy (HCM).
Critoph, CH +6 more
core +5 more sources
In the SFHI (State Funded Healthcare Institution) Republic’s Centre for Cardiology the method of alcohol septal ablation has been introduced in 2015. The paper presents one case of a successful treatment of a patient with hypertrophic cardiomyopathy with
I. E. Nikolaeva +5 more
doaj +1 more source
The authors describe a patient with hypertrophic cardiomyopathy with concomitant left ventricular outflow tract obstruction and aortic stenosis. Detailed haemodynamic assessment of the serial lesions was performed.
Priya Bansal +6 more
doaj +1 more source
Spatial and temporal changes in extracellular elastin and laminin distribution during lung alveolar development [PDF]
Lung alveolarization requires precise coordination of cell growth with extracellular matrix (ECM) synthesis and deposition. The role of extracellular matrices in alveogenesis is not fully understood, because prior knowledge is largely extrapolated from ...
Chen, Hui +9 more
core +2 more sources
Endocardial septal ablation for hypertrophic obstructive cardiomyopathy
Summary– Septal reduction therapy (SRT) is the accepted therapeutic option for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). At this time, surgical septal myectomy is the gold standard method, but alcohol septal ablation is an acceptable ...
Tolga Aksu +4 more
doaj +1 more source
Septal alcohol ablation and Heyde's syndrome revisited [PDF]
Abstract. Riis Hansen P, Hassager C (Gentofte University Hospital, Hellerup, Denmark). Septal alcohol ablation and Heyde's syndrome revisited. (Case Report). J Intern Med 2003; 253: 490–491.We describe a 57‐year‐old male with hypertrophic obstructive cardiomyopathy and occult blood loss.
P, Riis Hansen, C, Hassager
openaire +2 more sources
A Path to Implement Precision Child Health Cardiovascular Medicine. [PDF]
Congenital heart defects (CHDs) affect approximately 1% of live births and are a major source of childhood morbidity and mortality even in countries with advanced healthcare systems. Along with phenotypic heterogeneity, the underlying etiology of CHDs is
Brian Reemtsen +8 more
core +2 more sources
FIRST RESULTS OF MICROSPHERE EMBOLIZATION AS AN ALTERNATIVE FOR ALCOHOL IN PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION [PDF]
Farrando Sicilia, Jordi; Fuente Fuente ...
Vriesendorp, Pieter A. +5 more
core +1 more source
Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry [PDF]
Background The long‐term efficacy and safety of alcohol septal ablation ( ASA ) in patients with highly symptomatic hypertrophic obstructive cardiomyopathy has been demonstrated. The aim
Adlova, Radka +16 more
core +1 more source

